Neurodegenerative changes associated with β-amyloid deposition in the brains of mice carrying mutant amyloid precursor protein and mutant presenilin-1 transgenes

Experimental Neurology

Volumn 171, Issue 1, 2001, Pages 59-71

  Kurt, M A ^a,b   Davies, D C ^a   Kidd, M ^a   Duff, K ^c   Rolph, S C ^d   Jennings, K H ^d   Howlett, D R ^d  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b ULUDAG UNIVERSITY   (Turkey)

^c NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

^d GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; PRESENILIN 1;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ASTROCYTOSIS; CELL ULTRASTRUCTURE; CYTOPLASM; DISEASE MODEL; ENDOPLASMIC RETICULUM; GRAY MATTER; HISTOLOGY; MICROGLIA; MOUSE; NEUROPATHOLOGY; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; TRANSGENE; TRANSGENIC MOUSE; WHITE MATTER;

EID: 0034847176     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.2001.7717     Document Type: Article

References (54)

1. Studies on inhibition of β-amyloid formation in APP751-transfected IMR-32 cells and SPA4CT-transfected SHSY5Y cells in Alzheimer's disease
2. Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins
3. Generation of β-amyloid in the secretory pathway in neuronal and nonneuronal cells
4. Neuronal overexpression of mutant amyloid precursor protein results in prominent deposition of cerebrovascular amyloid
5. Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice
6. Platelets are the primary source of amyloid beta-peptide in human blood
7. Transgenic mice with Alzheimer presenilin 1 mutations show accelerated neurode-generation without amyloid plaque formation
8. Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid β-protein in both transfected cells and transgenic mice
9. Alzheimer's Aβ(1-42) is generated in the endoplasmic reticulum/intermediate compartment of NT2N cells
10. The pathogenesis of senile plaques
11. Increased amyloid-β42(43) in brains of mice expressing mutant presenilin 1
12. Cerebral amyloid angiopathy in the brains of patients with Alzheimer's disease: The CERAD experience, part XV
13. Microglial response to amyloid plaques in APPsw transgenic mice
14. Association of Aβ40-positive plaques with microglial cells in the brains of patients with Alzheimer's disease and in non-demented aged individuals
15. Astrocytes containing amyloid β-protein (Aβ)-positive granules are associated with Aβ40-positive diffuse plaques in the aged human brain
16. Formation of "dark" (argyrophilic) neurons of various origin proceeds with a common mechanism of biophysical nature (a novel hypothesis)
17. Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein
18. Presenilins: Genes for life and death
19. Amyloid, the presenilins and Alzheimer's disease
20. The Alzheimer family of diseases, many aetiologies, one pathogenesis?
21. Alzheimer's disease: The amyloid cascade hypothesis
22. Distinct sites of intracellular production of Alzheimer's disease Aβ 40/42 amyloid peptides
23. Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 genes
24. Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models
25. Correlative memory deficits, Aβ elevation and amyloid plaques in transgenic mice
26. Analysis of heterogeneous βA4 peptides in human cerebrospinal fluid by a newly developed sensitive Western blot assay
27. Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific Aβ monoclonals: Evidence that an initially deposited species is Aβ42(43)
28. Amyloid β-protein (Aβ) deposition: Aβ42(43) precedes Aβ40 in Down syndrome
29. Amyloid precursor processing and Aβ42 deposition in a transgenic mouse model of Alzheimer's disease
30. β-amyloid immunoreactivity in astrocytes in Alzheimer's disease brain: An electron microscope study
31. Processing of Amyloid precursor protein in human primary neurons and astrocyte cultures
32. The incidence of cerebral amyloid angiopathy in Alzheimer's disease
33. 42(43)
34. Comparison of neurodegenerative pathology in transgenic mice overexpressing V717F beta-amyloid precursor protein and Alzheimer's disease
35. Amyloid phenotype characterisation of transgenic mice overexpressing both mutant amyloid precursor protein and mutant presenilin 1 transgenes
36. Immunohistochemical analysis of cerebral cortical and vascular lesions in the primate Microcerebrus murinus reveal distinct amyloid β1-42 and β1-40 immunoreactivity profiles
37. Degeneration in vivo of rat hippocampal neurons by wild-type Alzheimer amyloid precursor protein overexpressed by adenovirus-mediated gene transfer
38. Age-dependent increase of amyloid β-protein (Aβ) 42 in the brain of mutant presenilin 2 transgenic mouse
39. Early association of reactive astrocytes with senile plaques in Alzheimer's disease
40. Detection of distinct isoform patterns of the β-amyloid precursor protein in human platelets and lymphocytes
41. The amyloid β-protein precursor is localized in smooth muscle cells of leptomeningeal vessels
42. Association of microglia in brains of APP23 transgenic mice
43. Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology
44. Amyloid beta protein and its 3-kDa fragment are present in the axoplasm fraction of the white matter in human brain
45. A simplified lead citrate stain for use in electron microscopy
46. Staining of tissue sections for electron microscopy with heavy metals
47. Quantitative histological analysis of amyloid deposition in Alzheimer's double transgenic mouse brain
48. Ultrastructural studies of the cells forming fibers in classical plaques
49. Some neuropathological aspects of Alzheimer's disease and its relevance to other disciplines
50. Interrelationship between beta-amyloid deposition and complement-activated oligodendroglia
51. Diffuse plaques associated with amyloid β protein, possibly showing a disappearing stage of senile plaques
52. Destabilisation of β-catenin by mutations in presenilin-1 potentiates neuronal apoptosis